Gatiquin-P Eye Drop is a combination ophthalmic preparation containing Gatifloxacin 0.3% w/v, a broad-spectrum fluoroquinolone antibiotic, and Prednisolone 1% w/v, a potent corticosteroid. This formulation is indicated for the treatment of bacterial infections of the eye where inflammation is also present. Gatifloxacin acts by inhibiting bacterial DNA gyrase and topoisomerase IV, thereby preventing bacterial replication and effectively eradicating susceptible gram-positive and gram-negative pathogens. Prednisolone exerts anti-inflammatory effects by suppressing the release of inflammatory mediators, reducing edema, redness, and pain associated with ocular infections. Gatiquin-P Eye Drop is commonly prescribed for conditions such as bacterial conjunctivitis, keratitis, and postoperative inflammation following ocular surgery. The dual action of antimicrobial and anti-inflammatory agents facilitates rapid symptom relief and promotes healing while minimizing tissue damage caused by inflammation. It is essential to use this medication under strict medical supervision to avoid potential side effects such as increased intraocular pressure or secondary infections. Patients should adhere to the prescribed dosage and duration to ensure optimal therapeutic outcomes and prevent resistance development. Gatiquin-P Eye Drop should not be used in viral or fungal eye infections unless specifically directed by a healthcare professional.